Article
NYU-Led Study Finds Removal of Gene Prevents Development of Aggressive Pancreatic Cancer in Mice
A study led by researchers from the NYU School of Medicine and the University of Michigan has found that the action of a gene called ATDC is required for the development of pancreatic cancer.
A study led by researchers from the NYU School of Medicine and the University of Michigan has found that the action of a gene called ATDC is required for the development of pancreatic cancer. These findings were demonstrated in a study of mice and human patient samples.
The research builds upon the theory that many cancer arise when adults cells switch back into more “primitive,” high-growth cell types, like those that drive fetal development. When this reversion happens in the presence of other genetic mistakes, a repair process meant to start and stop quickly remains unchecked.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
PROs Affirm Zongertinib’s Combination of Strong Response Rates With Low Toxicity
